Drugmaker touts benefits of fish oil derivative, experts reserve judgment

Irish pharmaceutical company Amarin sent a ...

Posted: Sep 25, 2018 12:33 PM
Updated: Sep 25, 2018 12:33 PM

Irish pharmaceutical company Amarin sent a glowing announcement to investors Monday that its drug Vascepa, a purified fish oil derivative, was linked to a 25% reduced risk of major cardiovascular events such as heart attack and stroke.

While some doctors saw this announcement as a stunning and unexpected result that could change medical practice, others are reserving their judgment until the company shares its data, which have not been published in a peer-reviewed journal.

Business and industry sectors

Business, economy and trade

Consumer products

Fats and oils

Food and drink

Food products

Kinds of foods and beverages

Banking, finance and investments

Cardiology

Cardiovascular disease

Derivatives markets

Diseases and disorders

Drug safety

Drug safety, efficacy and availability

Financial markets and investing

Health and medical

Medical fields and specialties

Pharmaceutical industry

Pharmaceuticals and biotechnology

Pharmaceuticals and prescription drugs

Securities trading

Energy and utilities

Oil and gas industry

"This trial certainly strengthens the idea that treating people with cardiovascular disease [and] with elevated triglycerides resulted in a reduction in cardiovascular events," said Dr. Howard Weintraub, a preventive cardiologist and clinical director of the Center for the Prevention of Cardiovascular Disease at NYU Langone Health. Weintraub was a co-investigator of the trial.

But experts say these findings were not widely expected. The science behind fish oil and cardiovascular health has been inconclusive, and many studies have not shown a benefit. Vascepa is derived from a single omega-3 fatty acid isolated from fish.

"I want to see the numbers," said cardiologist Dr. Russell Luepker, a Mayo professor of public health at the University of Minnesota who was not involved in the trial. "This is just a tiny fraction of the data that they undoubtedly have. And undoubtedly what they've given us is the best data they have.

"This is almost like a press release to generate buzz."

Amarin shares closed on Friday at $2.99, opened Monday above $10 and rose throughout the day.

Cardiologist Dr. Rita Redberg described the announcement as "remarkably free of data" and said that initial buzz surrounding drug-related announcements hasn't always panned out.

"This is potentially very interesting. I just don't think there's enough here to know," said Redberg, also a professor of medicine at the University of California, San Francisco.

In its statement, the drug maker also cautioned, "Existing and prospective investors are cautioned not to place undue reliance on topline results."

More results from the trial will be presented on November 10 at a meeting of the American Heart Association in Chicago. Investigators say they also plan to publish the results in a peer-reviewed journal, according to the company statement.

Weintraub said that the trial could have succeeded where others failed for three reasons: the specific fish oil component they used, the higher dose of four grams per day and the type of patient it was given to.

The 8,179 patients in the double-blinded study had LDL levels in the normal range, controlled by statins, as well as "persistent elevated triglycerides," another kind of lipid, ranging from 150 to 499 mg/dL. In addition, they either had "established cardiovascular disease," or they had Type 2 diabetes and at least one other cardiovascular risk factor. Patients were followed for a median 4.9 years.

Weintraub said that while there have been plenty of studies on statins and cholesterol, triglycerides haven't gotten the same attention on their own -- part of what makes this trial unique.

"I've always viewed triglycerides as the Rodney Dangerfield of lipids -- they didn't get enough respect," he said.

Still, he said it's unclear whether the drug prevents cardiovascular events by acting directly on triglycerides, or whether they are a marker for some other process going on in our bodies -- "secret sauce," as he says. Or perhaps some combination of the two, he added.

The company described the drug as "well tolerated," with "similar" rates of adverse events between those who got the drug and those who received a placebo.

The drug was approved by the US Food and Drug Administration in 2012 to lower triglycerides in excess of 500 mg/dL.

Roughly a quarter of Amercans age 20 and older have elevated triglycerides, according to data from the National Health and Nutrition Examination Survey. High triglycerides are associated with an increased risk of cardiovascular disease in combination with low HDL and high LDL, according to the US Centers for Disease Control and Prevention. The agency says lifestyle choices can help lower triglycerides, including exercise, weight loss, diet and quitting smoking.

Heart disease is the top cause of death in the US, leading to the deaths of more than 600,000 per year.

"There's still some debate on how important [triglycerides are], but I've gradually come to the opinion that it is important. But whether treating it is important -- there are a bunch of trials that have been, at best, ambiguous about that," Luepker said.

A bottle of 120 1-gram capsules of Vascepa has an average cash price of nearly $350, though many consumers will likely pay less, according to GoodRx, whose numbers are based on sources including published price lists, purchases, claims records and pharmacy data.

Weintraub said that the topline results may have granted a sneak peek, but that's hardly the end of the story. A deeper dive into the data could help illuminate whose risk was slashed the most, to what degree, and what other differences were seen between subgroups in the trial. For example, do the people with the highest triglycerides derive the greatest benefit? Is the effect the same in men and women, in people with or without diabetes?

"It may turn out to be worthwhile," said Luepker, but the announcement "does not give me enough information to make a reasoned judgment of whether this is good, bad or indifferent."

Weintraub, however, said that he wouldn't hesitate to prescribe the drug to patients like those in the trial, given what he described as a very favorable side effect profile and strong topline results.

"I would do it in a heartbeat," he said.

Minnesota Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 122812

Reported Deaths: 2287
CountyConfirmedDeaths
Hennepin32050965
Ramsey13185346
Dakota9146133
Anoka7955148
Stearns525534
Washington517267
Scott315634
Olmsted305029
St. Louis258563
Wright224714
Nobles211716
Clay200843
Blue Earth19587
Carver16867
Rice15629
Sherburne153221
Kandiyohi15194
Mower148912
Winona116718
Lyon9146
Waseca9089
Crow Wing86821
Chisago8312
Benton8265
Beltrami7537
Otter Tail7206
Steele7162
Todd6922
Itasca67117
Nicollet66417
Freeborn6314
Douglas5923
Martin58416
Le Sueur5825
Morrison5776
McLeod5663
Watonwan5634
Pine5040
Goodhue49711
Polk4894
Becker4833
Isanti4803
Chippewa3733
Carlton3721
Dodge3600
Mille Lacs3467
Pipestone32416
Wabasha3200
Cass3045
Meeker3043
Hubbard3012
Brown2903
Rock2861
Yellow Medicine2655
Cottonwood2610
Redwood24810
Murray2443
Fillmore2350
Sibley2353
Renville22511
Unassigned22053
Faribault2080
Swift1911
Jackson1891
Roseau1890
Kanabec18710
Houston1801
Wadena1790
Lincoln1640
Stevens1631
Pennington1621
Koochiching1604
Aitkin1511
Pope1420
Big Stone1270
Lac qui Parle1222
Wilkin1224
Lake1000
Norman930
Mahnomen911
Grant864
Marshall861
Clearwater740
Red Lake562
Traverse490
Lake of the Woods401
Kittson270
Cook110

Iowa Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 106765

Reported Deaths: 1522
CountyConfirmedDeaths
Polk17906281
Woodbury678786
Johnson562330
Black Hawk517196
Linn5020123
Dubuque463852
Scott402433
Story383217
Dallas328843
Pottawattamie294044
Sioux228211
Buena Vista219512
Marshall192236
Webster166414
Plymouth153324
Wapello147062
Clinton134625
Muscatine132357
Crawford130312
Cerro Gordo122223
Des Moines12099
Warren11436
Carroll10238
Jasper101934
Henry9735
Marion92010
Tama89336
Lee8689
Dickinson6837
Wright6791
Delaware6728
Boone6718
Bremer6117
Washington60611
Mahaska60122
Harrison5628
Jackson5253
Lyon5117
Benton4971
Louisa49015
Clay4814
Hamilton4313
Winneshiek4299
Poweshiek42811
Hardin4215
Winnebago41916
Kossuth4150
Floyd41211
Jones4053
Emmet39314
Buchanan3893
Cedar3795
Iowa3756
Franklin36918
Guthrie36414
Cherokee3622
Sac3603
Clayton3503
Page3450
Shelby3411
Butler3402
Fayette3372
Madison3372
Mills3341
Allamakee3248
Chickasaw3191
Clarke3083
Cass3022
Palo Alto2831
Grundy2794
Humboldt2793
Hancock2724
Calhoun2573
Howard2458
Osceola2450
Monroe23711
Mitchell2270
Monona2261
Taylor2202
Union2083
Pocahontas2032
Appanoose1983
Jefferson1881
Lucas1796
Fremont1781
Ida1762
Greene1710
Van Buren1562
Davis1544
Montgomery1525
Keokuk1361
Audubon1281
Worth1260
Adair1231
Decatur1220
Wayne1113
Ringgold802
Adams670
Unassigned250
Rochester
Overcast
31° wxIcon
Hi: 36° Lo: 25°
Feels Like: 25°
Mason City
Overcast
33° wxIcon
Hi: 38° Lo: 27°
Feels Like: 27°
Albert Lea
Broken Clouds
34° wxIcon
Hi: 37° Lo: 27°
Feels Like: 28°
Austin
Overcast
34° wxIcon
Hi: 38° Lo: 27°
Feels Like: 34°
Charles City
Scattered Clouds
32° wxIcon
Hi: 38° Lo: 28°
Feels Like: 23°
Tracking Snow
KIMT Radar
KIMT Eye in the sky

Latest Video

Image

Chez Bojji now open

Image

Ways to save you money this winter

Image

Sean's Weather 10/19

Image

Working to save the bees

Image

Suicide hotline number changing

Image

Sunday weather

Image

Minnesota's COVID numbers on the rise

Image

Bagging groceries for veterans

Image

Saturday night weather

Image

Saturday Weather

Community Events